salvianolate

Small moleculeexperimental

Salvia miltiorrhiza, also known as red sage, redroot sage, Chinese sage, or danshen, is a perennial plant in the genus Salvia, highly valued for its roots in traditional Chinese medicine. Native to China and Japan, it grows at 90 to 1,200 m elevation, preferring grassy places in forests, hillsides, and along stream banks. The specific epithet miltiorrhiza means "red ochre root". — Wikipedia

Clinical trial activity

11 trials · 18 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
5

Earliest trial started Jan 1, 2013 (NCT01825759)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetAntioxidant

    antioxidant

Chemistry & pharmacology

Loading structure…

SMILES

O=C(/C=C/c1ccc(O)c(O)c1/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O
Mol. weight
494.45 g/mol
Lipinski Ro5
1 violation(s)
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • danshen gegen capsule
  • salvianolate
  • salvianolate
  • salvianolic acid

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04931628N/ASep 1, 2021Ningbo No. 1 Hospital, Red Cross Hospital, Hangzhou, China, Wenzhou Medical University, Xiaoshan People's Hospital, Zhejiang Chinese Medical University, Zhejiang University
NCT03908242Phase 1Apr 8, 2019Peking University
NCT03791463Phase 1Dec 20, 2018Peking University
NCT03791125Phase 1Nov 20, 2018Chinese Academy of Medical Sciences, Peking University, Shandong Huizhi Pharmaceutical Technology Co., Ltd.
NCT03306550N/AOct 10, 2017China Academy of Chinese Medical Sciences
NCT03045562Phase 4Jan 20, 2017Fudan University, Green Valley Group of China
NCT02870764Phase 4Sep 1, 2016Huazhong University of Science and Technology, Taiyuan Fourth People's Hospital
NCT03037047Phase 4May 11, 2016Green Valley Group of China, People's Liberation Army of China
NCT02694848Phase 4Feb 1, 2016China Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Traditional Chinese Medicine, People's Liberation Army of China
NCT02380794Phase 2Sep 1, 2015Chinese University of Hong Kong
NCT01825759Phase 4Jan 1, 2013Sichuan University
Showing 11 of 11 trials
Page 1 / 1

Organizations

Research & Development (18)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Peking UniversityAcademic/Hospital3312018
China Academy of Chinese Medical SciencesAcademic/Hospital2222016
Green Valley Group of ChinaFor profit2212016
People's Liberation Army of ChinaGovernment2012016
Chinese Academy of Medical SciencesAcademic/Hospital1012018
Chinese University of Hong KongAcademic/Hospital1112015
Fudan UniversityAcademic/Hospital1012017
Guangdong Provincial Hospital of Traditional Chinese MedicineAcademic/Hospital1012016
Huazhong University of Science and TechnologyAcademic/Hospital1012016
Ningbo No. 1 HospitalAcademic/Hospital1012021
Red Cross Hospital, Hangzhou, ChinaAcademic/Hospital1012021
Shandong Huizhi Pharmaceutical Technology Co., Ltd.Government1012018
Sichuan UniversityAcademic/Hospital1112013
Taiyuan Fourth People's HospitalAcademic/Hospital1112016
Wenzhou Medical UniversityAcademic/Hospital1012021
Xiaoshan People's HospitalAcademic/Hospital1012021
Zhejiang Chinese Medical UniversityAcademic/Hospital1012021
Zhejiang UniversityAcademic/Hospital1112021
18 organizations
Page 1 / 1